News Releases

Archives: Search / 2018 / 2017 / 2016 / 2015 / 2014 / 2013 / 2012

201120102009200820072003

Jan 3, 2018

Nektar Therapeutics' (Nasdaq: NKTR) President and Chief Executive Officer, Howard Robin, is scheduled to present at the upcoming 36th Annual J.P. Morgan Healthcare Conference in San Francisco on...

More
Nov 27, 2017

Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming Piper Jaffray 29th Annual Healthcare Conference in New York City on Tuesday,...

More
Nov 22, 2017

Nektar Therapeutics (Nasdaq: NKTR) announced today several promotions on its executive leadership team: Stephen Doberstein, Ph.D., has been promoted to Senior Vice President, Research &...

More
Nov 11, 2017
Interim data from the dose-escalation phase of the PIVOT-02 trial highlighted as an oral presentation

Nektar Therapeutics (Nasdaq: NKTR) and Bristol-Myers Squibb (NYSE: BMY) today announced the first presentation of data from the PIVOT-02 Phase 1/2 Study, which is designed to evaluate the...

More
Nov 10, 2017

Nektar Therapeutics (Nasdaq: NKTR) announced today that its corporate presentation will be webcast at the upcoming Jefferies 2017 London Healthcare Conference in London on Wednesday, November 15,...

More
 

print email rss
 
 
Site Map Privacy Terms of Use Compliance Policy Trademarks Site Users Guide